64896-509-02 : NDC 2026 Code

64896-509-02 : Dihydroergotamine Mesylate ( Brekiya )

Additionally :

You can get information about “64896-509-02” NDC code in 64896-509-02 in HTML format

HTML | 64896-509-02 in TXT (Plain Text) format

TXT | 64896-509-02 in PDF (Portable Document Format)

PDF | 64896-509-02 in XML format

XML formats.

NDC Code : 64896-509-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "64896-509-02",
    "PackageDescription": "4 POUCH in 1 CARTON (64896-509-02)  / 1 SYRINGE in 1 POUCH / 1 mL in 1 SYRINGE (64896-509-01) ",
    "NDC11Code": "64896-0509-02",
    "ProductNDC": "64896-509",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Brekiya",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dihydroergotamine Mesylate",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20250516",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA215400",
    "LabelerName": "Amneal Pharmaceuticals LLC",
    "SubstanceName": "DIHYDROERGOTAMINE MESYLATE",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Ergotamine Derivative [EPC], Ergotamines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250516",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}